CAR T-cell therapy is a new approach to treating certain types of lymphoma, multiple myeloma and acute lymphoblastic leukemia that have not responded to two prior types of treatment.
Car T Cell Therapy
You are here
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
CAR T-cell and other new drugs are expanding treatment options for patients with myeloma.
Learn how new cellular therapies, like CAR T-Cell therapy, can help patients with certain blood disorders.
¿Qué es la terapia con el receptor de antígeno quimérico (CAR-T)? ¿Quién es candidato para la terapia CAR-T?
Learn how CAR T therapy works to fight cancer, who is a candidate for CAR T therapy, the side effects and whether it can cure or prolong life.